Dr. Matteo Zurlo is a Postdoctoral Researcher at the Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Laboratorio di Bioscienze, Meldola, Italy. He completed his PhD studies in Biomedical and Biotechnological Sciences at the University of Ferrara, Ferrara, Italy. He has published 34 papers in various journals. His research interests mainly include β-thalassemia, fetal hemoglobin, γ-globin, HbF induction, K562 cells, Cinchona alkaloids, cinchonidine, quinidine, cinchonine, and combined treatments.